ArticleThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale2026
Characterization of Hospitalized Patients With Dengue Fever in Can Tho City: A Cross-Sectional Analysis, 2018-2019.
Article in The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Characterization of Hospitalized Patients With Dengue Fever in Can Tho City: A Cross-Sectional Analysis, 2018-2019.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dengue poses a significant public health issue in tropical and subtropical countries, especially in urban areas. Can Tho, the fourth-largest city in Vietnam's Mekong Delta, is highly vulnerable to climate change. This study characterizes dengue fever (DF) and identifies factors linked to severe disease in hospitalized patients from 2018 to 2019. We analyzed the clinical manifestations of 123 patients, along with blood count tests, RT-PCR, the NS1 antigen rapid test, and ELISA for IgM and IgG antibodies, upon admission. The results revealed that 88.6% of dengue patients were under 15 years, primarily treated at Can Tho Pediatric Hospital, with 66.7% experiencing secondary infections. Warning signs included high fever, rapid pulse, abdominal pain (54.4%), nausea/vomiting (43.2%), and bleeding (5.7%). DEN-1, DEN-2, and DEN-4 circulated during the study, with DEN-1 predominating in 2018 (85.7%) and both DEN-1 and DEN-2 as primary causes in 2019 (52.2% and 39.1%, respectively). The DEN-2 serotype and secondary infections may significantly contribute to severe dengue, and further research on dengue immunity is essential for understanding the effects of dengue vaccination.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.